%0 Journal Article
%T Pituitary Complications of Checkpoint Inhibitor Use.
%A Chamorro-Pareja N
%A Faje AT
%A Miller KK
%J Endocrinology
%V 165
%N 9
%D 2024 Jul 26
%M 39001874
%F 5.051
%R 10.1210/endocr/bqae084
%X Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered clinical entity with the emergence of antitumor immunotherapy. This mini-review aims to consolidate current knowledge, encompassing the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of pituitary complications of immune checkpoint inhibitor use.